Skip to content
10-Q

Quarterly Report

PROTO SCRIPT PHARMACEUTICAL CORP

0001078782-16-003830

← back to feed
Filed
Nov 18, 2016 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2016 · Nov 17, 2016 3.05M sh
Operating Cash Flow Q2 2016 · Jun 30, 2016 $41.47K
Operating Cash Flow Q2 2016 · Jun 30, 2015 $30.97K
Stockholders Equity Q2 2016 · Jun 30, 2016 $83.99K
Stockholders Equity Q2 2016 · Dec 31, 2015 $62.24K
Total Liabilities Q2 2016 · Jun 30, 2016 $160.81K
Total Liabilities Q2 2016 · Dec 31, 2015 $136.7K
Current Assets Q2 2016 · Jun 30, 2016 $231.7K
Current Assets Q2 2016 · Dec 31, 2015 $183.5K
Total Assets Q2 2016 · Jun 30, 2016 $244.8K
Total Assets Q2 2016 · Dec 31, 2015 $198.94K
Capex Q2 2016 · Jun 30, 2015 $1.36K
Cash And Equivalents Q2 2016 · Jun 30, 2015 $13.81K
Cash And Equivalents Q2 2016 · Dec 31, 2014 $31.15K
Sga Expense Q2 2016 · Jun 30, 2015 $193.53K
Sga Expense Q2 2016 · Jun 30, 2015 $408.58K
Net Income Q2 2016 · Jun 30, 2015 −$12.01K
Net Income Q2 2016 · Jun 30, 2015 −$18.68K
Gross Profit Q2 2016 · Jun 30, 2015 $181.53K
Gross Profit Q2 2016 · Jun 30, 2015 $389.9K
Cost Of Revenue Q2 2016 · Jun 30, 2015 $52.16K
Cost Of Revenue Q2 2016 · Jun 30, 2015 $155.54K